According to Medicamen Biotech latest financial reports the cash on hand of MEDICAMEQ is $2.48M, an increase of 443.26% to 2022. At the end of 2022 company had $455.73K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $2.48M | 443.26% |
2022 | $455.73K | -1.69% |
2021 | $463.58K | 127.58% |
2020 | $203.70K | -76.74% |
2019 | $875.79K | - |